Development of a nasal adenovirus-based vaccine: Effect of concentration and formulation on adenovirus stability and infectious titer during actuation from two delivery devices
Authors:
- 25 February 2010
- Vol. 28 (9) , 2137-2148
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Mucosal vaccines: novel advances in technology and deliveryExpert Review of Vaccines, 2009
- Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal ruleNature Reviews Microbiology, 2009
- Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based VaccinePLOS ONE, 2009
- Disease modeling for Ebola and Marburg virusesDisease Models & Mechanisms, 2009
- Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in MicePLOS ONE, 2008
- Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditionsAntiviral Research, 2008
- Mucosal Delivery of Adenovirus‐Based Vaccine Protects against Ebola Virus Infection in MiceThe Journal of Infectious Diseases, 2007
- The ecology of Ebola virusTrends in Microbiology, 2007
- How Ebola and Marburg viruses battle the immune systemNature Reviews Immunology, 2007
- Estimation of the global burden of disease attributable to contaminated sharps injuries among health‐care workersAmerican Journal of Industrial Medicine, 2005